- Gynecology
- Sang Il-Park Head of Department
- Specialty
- Diagnosis and Treatment of Gynecologic Cancers (Cervical Cancer, Endometrial Cancer, Ovarian Cancer), Gynecologic Endoscopic Surgery, Menopausal Disorders, Robotic Surgery
- Month
- 06
- Available
- Fully Booked
Please note that online reservations may not be available for some doctors depending on the department’s circumstances.
Appointment
Education & Experience
Education
- Pusan National University College of Medicine / MS / PhD
Experience
- 2019 - Present Author Committee Member, 〃Gynecologic Oncology〃 textbook
- 2016 - Present Editorial Board Member, Journal of Gynecology Oncology
- 2016 - Present Subcommittee Member, Cervical Cancer, Korean Gynecologic Oncology Group
- 2010 - Present Head of Department, Obstetrics and Gynecology, Nuclear Hospital, Dongnam Institute of Radiological ＆ Medical Sciences
- 2018 - 2023 President, Dongnam Institute of Radiological ＆ Medical Sciences
- 2018 - 2018 Acting Director, Research Center, Dongnam Institute of Radiological ＆ Medical Sciences
- 2017 - 2018 Director, Department of Clinical Services, Dongnam Institute of Radiological ＆ Medical Sciences
- 2013 - 2015 Director, Cancer Prevention Screening Center, Dongnam Institute of Radiological ＆ Medical Sciences
- 2012 - 2013 Head, Strategy Promotion Team, Dongnam Institute of Radiological ＆ Medical Sciences
- 2010 - 2012 Head, Education＆Training Team, Dongnam Institute of Radiological＆Medical Sciences
- 2009 - 2010 Director, Obstetrics and Gynecology, Korea Institute of Radiological＆Medical Sciences
Key Activities
- Author Committee Member, 〃Gynecologic Oncology〃 textbook
- Vice Chair, Busan Metropolitan City Nuclear Safety Countermeasures Committee
- Editorial Board Member, Journal of Gynecology Oncology
- Subcommittee Member, Korean Gynecologic Oncology Group
- Regular Member, AAGL (American Association of Gynecologic Laparoscopists)
- Regular Member, Korean Cancer Association
- Regular Member, Korean Society of Gynecologic Oncology
Awards
No awards registered.
Research & Publications
- Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography. Onkologie 2013;36:169-174
- The Clinicopathological Relevance for The Expression of Secreted Protein Acidic and Rich in Cysteine in Epithelial Ovarian Tumors. Korean J Obstet Gynecol 2011; 54(12): 770-777
- The role of adjuvant therapy in FIGO stage IB-IIA cervical cancers with intermediate risk factors. Korean J Obstet Gynecol 2007:93 141~14
- Recent Clinical Review : Current status of application of the secondary cytoreductive surgery for patients with epithelial ovarian carcinomas. Korean J Obstet Gynecol 2007; 50(8): 1057-1063
- Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):794-9.
- Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
- Efficacy of fibrin sealant in reducing hemorrhage after a loop electrosurgical excision procedure. 2012;74(1): 1-5. doi: 10.1159/000333266. Epub 2012 Jun 27
- Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):219-23.
- Risk of metastatic ovarian involvement in nongynecologic malignancies. Int J Gynecol Cancer. 2012 Jan;22(1):3-8.
- Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease. J Korean Med Sci. 2010 Jul;25(7):1029-33.
- Modalities for evaluation of tumor size in cervical cancer. Choi SC, Kim K, Park SI, Kim BJ, Kim MH, Ryu SY, Lee ED, Lee KH. J Gynecol Oncol. 2008 Sep;19(3):205.
- Clinicopathologic characteristics and prognostic factors of primary peritoneal carcinoma. Korean J Obstet Gynecol 2009:52, 212~219(Korean J Obstet Gynecol (Korean J Obstet Gynecol (Korean J Obstet Gynecol.